Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

September 20, 2025

Study Completion Date

December 20, 2025

Conditions
Primary Immune Thrombocytopenia
Interventions
DRUG

corticosteroids combined with immunoglobulin and romiplostim

"Romiplostim N01, starting dose of 1 µg/kg, subcutaneous injection, given on the third day of IVIG, once a week, for up to one month.~IVIG, 400mg/kg/d, intravenous administration, continuous administration for 3-5 days.~Prednisone, 0.8mg/kg/d, taken orally or intravenously, for up to one month."

Trial Locations (1)

430000

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Institute of Hematology & Blood Diseases Hospital, China

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER